Service Screening with Mammography in Sweden: Evaluation of Effects of Screening on Breast Cancer Mortality in Age Group 40-49 Years

References

• Larsson LG, Andersson I, Bjurstam N, et al. Updated overview of the Swedish randomized trials on breast cancer screening with mammography: age group 40-49 at random-ization. J Natl Cancer Inst Monogr 1997; 22: 57–61.
   Google Scholar
• Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mam-mographic Screening Program. J Natl Cancer Inst Monogr 1997; 22: 63–7.
   Google Scholar
• Bjurstam N, Björneld L, Duffy SW, et al. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. J Natl Cancer Inst Monogr 1997; 22: 53–5.
   Google Scholar
• McCann J, Wait S, Séradour B, et al. A comparison of the performance and impact of breast cancer screening programmes in East Anglia, UK and Bouches Du Rh6ne, France. Eur J Cancer 1997; 33: 429–35.
   Google Scholar
• van den Akker-van Marie ME, Reep-van den Bergh CMM, Boer R, et al. Breast cancer screening in Navarra: interpreta-tion of a high detection rate at the first screening round and a low rate at the second round. Int .1- Cancer 1997; 73: 464–9.
   Google Scholar
• Thurfjell EL, Lindgren JA. Population-based mammography screening in Swedish clinical practice: prevalence and inci-dence screening in Uppsala County. Radiology 1994; 193: 351–7.
   PubMed Web of Science ®Google Scholar
• Schouten LJ, de Rijke JM, Schlangen JTh, et al. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands. J Med Screen 1998; 5: 37–41.
   PubMed Web of Science ®Google Scholar
• Vitak B. Invasive interval cancers in the Ostergotland Mam-mographic Screening Programme: radiological analysis. Eur Radiol 1998; 8: 639–46.
   PubMed Web of Science ®Google Scholar
• McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 1998; 5: 42–8.
   Google Scholar
• Lenner P, Jonsson H. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen 1997; 4: 6–9.
   PubMedGoogle Scholar
• Tabar L, Fagerberg CJG, Gad A, et al. Reduction in mortal-ity from breast cancer after mass screening with mammogra-phy. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829–32.
   Google Scholar
• Hakama M, Pukkala E, Heikkila M, et al. Effectiveness of the public health policy for breast cancer screening in Fin-land: population based cohort study. Br Med J 1997; 314: 864–7.
   PubMed Web of Science ®Google Scholar
• Breslow NE, Day NE. Vol. II. Statistical methods in cancer research. The design and analysis of cohort studies. Lyon: IARC, 1987: 131–8.
   Google Scholar
• Venables WN, Ripley BD. Modern applied statistics with S-PLUS. 2nd ed. New York: Springer, 1997.
   Google Scholar
• Mattsson B, Wallgren A. Completeness of the Swedish Can-cer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305–13.
   Google Scholar
• Cancer incidence in Sweden 1995. Centre for Epidemiology. National Board of Health and Welfare. Stockholm: Nordst-edts tryckeri AB, 1998.
   Google Scholar
• Törnberg S, Carstensen J, Hakulinen T, et al. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. J Med Screen 1994; 1: 184–7.
   Google Scholar
• Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Reg-istries. Br Med J 1995; 311: 1391–5.
   PubMed Web of Science ®Google Scholar
• Törnberg S. A survey on mammography examinations per-formed in private clinics during the period 1992–93 (in Swedish). Socialstyrelsens aktiva uppföljning. Stockholm: So-cialstyrelsen, 1994: 17–20.
   Google Scholar
• Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. J Natl Cancer Inst Monogr 1997; 22: 27–30.
   Google Scholar